We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
AUM
$772M
AUM Growth
+$48.7M
Cap. Flow
+$20.1M
Cap. Flow %
2.6%
Top 10 Hldgs %
48.69%
Holding
66
New
1
Increased
25
Reduced
7
Closed
3

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$17.8M
2
IDXX icon
Idexx Laboratories
IDXX
+$14.2M
3
MCD icon
McDonald's
MCD
+$14M
4
PYPL icon
PayPal
PYPL
+$3.5M
5
BDX icon
Becton Dickinson
BDX
+$2.69M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$13.3M
2
EW icon
Edwards Lifesciences
EW
+$12.4M
3
CVS icon
CVS Health
CVS
+$6.65M
4
ISRG icon
Intuitive Surgical
ISRG
+$5.93M
5
EMR icon
Emerson Electric
EMR
+$2.81M

Sector Composition

Rank Sector Weight
1 Technology 28.22%
2 Financials 13.97%
3 Healthcare 13.58%
4 Consumer Discretionary 13.16%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.91T
$57.6M 7.46%
428,654
+4,603
+1% +$634K
AAPL icon
2
Apple
AAPL
$4.9T
$51.1M 6.61%
203,931
-3,174
-2% -$748K
MSFT icon
3
Microsoft
MSFT
$2.93T
$50.6M 6.55%
119,931
+2,187
+2% +$932K
META icon
4
Meta Platforms (Facebook)
META
$1.64T
$40.4M 5.23%
68,945
+2,232
+3% +$1.31M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.23T
$38.7M 5.02%
204,627
+7,154
+4% +$1.25M
AMZN icon
6
Amazon
AMZN
$2.66T
$37.8M 4.9%
172,453
+5,008
+3% +$1.02M
GS icon
7
Goldman Sachs
GS
$314B
$28.9M 3.75%
50,541
+1,691
+3% +$943K
ABBV icon
8
AbbVie
ABBV
$450B
$24M 3.11%
135,004
+4,019
+3% +$739K
MA icon
9
Mastercard
MA
$480B
$23.8M 3.09%
45,239
+1,656
+4% +$857K
WFC icon
10
Wells Fargo
WFC
$265B
$23M 2.98%
327,618
+12,128
+4% +$828K
BA icon
11
Boeing
BA
$169B
$22.3M 2.89%
126,269
+113,623
+898% +$17.8M
HON icon
12
Honeywell
HON
$71.3B
$22.3M 2.88%
104,529
+2,992
+3% +$624K
ISRG icon
13
Intuitive Surgical
ISRG
$122B
$21.4M 2.77%
40,943
-11,389
-22% -$5.93M
MRVL icon
14
Marvell Technology
MRVL
$169B
$20.9M 2.71%
189,114
-25,717
-12% -$2.39M
ADI icon
15
Analog Devices
ADI
$183B
$20.7M 2.68%
97,261
+3,567
+4% +$789K
BDX icon
16
Becton Dickinson
BDX
$43.6B
$20.1M 2.6%
88,594
+11,633
+15% +$2.69M
CSX icon
17
CSX Corp
CSX
$94.3B
$20M 2.59%
619,471
+40,611
+7% +$1.39M
TGT icon
18
Target
TGT
$63.4B
$18.6M 2.41%
137,858
+3,268
+2% +$468K
EMR icon
19
Emerson Electric
EMR
$78.2B
$18.2M 2.36%
146,892
-23,127
-14% -$2.81M
SYY icon
20
Sysco
SYY
$39.1B
$17.8M 2.3%
232,325
+6,709
+3% +$514K
LOW icon
21
Lowe's Companies
LOW
$117B
$16.8M 2.17%
68,022
+1,974
+3% +$527K
SBUX icon
22
Starbucks
SBUX
$120B
$16.6M 2.15%
181,599
+5,306
+3% +$513K
C icon
23
Citigroup
C
$217B
$14.5M 1.88%
205,816
+7,421
+4% +$500K
ADBE icon
24
Adobe
ADBE
$94.3B
$14.4M 1.87%
32,408
+927
+3% +$459K
MCD icon
25
McDonald's
MCD
$190B
$14.3M 1.86%
49,445
+46,867
+1,818% +$14M

Similar funds

Waycross Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Waycross Partners held 66 positions worth $772M, up 6.7% from $723M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Waycross Partners's Q4 2024 filing shows 1 new, 25 increased, 7 reduced and 3 closed positions. Its largest new stake was Idexx Laboratories: 32,438 shares worth $13.4M. The largest sale was Visa, an estimated $13.3M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

  • Waycross Partners's largest Q4 2024 buy was Idexx Laboratories: 32,438 shares worth $13.4M.
  • Waycross Partners added most to Boeing in Q4 2024, an estimated $17.8M increase.
  • Waycross Partners's biggest Q4 2024 reduction was Visa, cutting an estimated $13.3M.
  • Waycross Partners fully exited Edwards Lifesciences in Q4 2024, selling an estimated $12.4M.
  • Waycross Partners's ten largest holdings make up 49% of its $772M portfolio in Q4 2024.
  • Waycross Partners opened 1 new position and closed 3 in Q4 2024.
  • Waycross Partners's portfolio value rose 6.7% quarter-over-quarter to $772M.

Based on Waycross Partners's 13F filing for Q4 2024, filed 31 Jan 2025.